Zach Scheiner

Director/Board Member at NKARTA, INC.

Net worth: - $ as of 30/07/2026

49 year

96 connections

Health Technology

Finance

Consumer Services

Profile

Zachary Scheiner currently serves as Independent Director at SpyGlass Pharma, Inc. since 2023; Director at Adagio Medical, Inc., LENZ Therapeutics Operations, Inc., and Nkarta, Inc. since 2020; Director at Exo Imaging, Inc. since 2021; Director at Sydnexis, Inc. since 2017; Principal at RA Capital Management LP (Private Equity) since 2017; and Principal at RA Capital Management LP since 2015.
Former roles include Independent Director at LENZ Therapeutics, Inc. from 2024 to 2026 and Chief Science Officer at California Institute for Regenerative Medicine from 2008 to 2015.
Education includes a doctorate from the University of Washington conferred in 2007 and an undergraduate degree from Yale University conferred in 1997.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
-.--%	14/06/2026	0 ( -.--% )	- $	30/07/2026
NKARTA, INC. -.--%	09/06/2026	0 ( -.--% )	- $	30/07/2026
SPYGLASS PHARMA, INC. -.--%	04/02/2026	0 ( -.--% )	- $	30/07/2026

Zach Scheiner active positions

Companies	Position	Start
NKARTA, INC.	Director/Board Member	31/01/2020
SPYGLASS PHARMA, INC.	Director/Board Member	30/06/2023
RA Capital Management LP RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization.	Analyst-Equity	31/03/2015
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement.	Private Equity Investor	30/11/2017
Adagio Medical, Inc. Adagio Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which focuses in cardiology	Director/Board Member	31/10/2020
Exo Imaging, Inc. Exo Imaging, Inc. Medical SpecialtiesHealth Technology Develops handheld ultrasound devices and AI for imaging & therapeutic applications	Director/Board Member	31/05/2021
Sydnexis, Inc. Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Director/Board Member	30/09/2017
LENZ Therapeutics, Inc. LENZ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops aceclidine-based eye drops	Director/Board Member	31/10/2020

All active positions of Zach Scheiner

Former positions of Zach Scheiner

Companies	Position	End
California Institute for Regenerative Medicine California Institute for Regenerative Medicine General GovernmentGovernment Provides medical services	Chief Tech/Sci/R&D Officer	28/02/2015

See the detail of Zach Scheiner's experience

Training of Zach Scheiner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zach Scheiner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
RA Capital Management LP RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization.	Finance
University of Washington University of Washington Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
California Institute for Regenerative Medicine California Institute for Regenerative Medicine General GovernmentGovernment Provides medical services	Government
Adagio Medical, Inc. Adagio Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which focuses in cardiology	Health Technology
Exo Imaging, Inc. Exo Imaging, Inc. Medical SpecialtiesHealth Technology Develops handheld ultrasound devices and AI for imaging & therapeutic applications	Health Technology
Sydnexis, Inc. Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Nkarta, Inc. Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment	Health Technology
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement.	Finance
LENZ Therapeutics, Inc. LENZ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops aceclidine-based eye drops	Health Technology
SpyGlass Pharma Inc SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients	Health Technology